195
Participants
Start Date
December 17, 2023
Primary Completion Date
January 15, 2027
Study Completion Date
February 28, 2027
Pterygopalatine Fossa Nerve Block with Ropivacaine and Dexamethasone
Each PPF-active nerve block will consist of 20mg (4ml) ropivacaine plus 4mg (1ml) dexamethasone
Placebo Pteryogpalatine Fossa Injection
Each placebo PPF-injection will consist of 5ml normal saline
RECRUITING
Albany Medical College, Albany
RECRUITING
University of Rochester Medical College, Rochester
NOT_YET_RECRUITING
Thomas Jefferson University, Philadelphia
RECRUITING
Johns Hopkins University, Baltimore
RECRUITING
Emory University, Atlanta
RECRUITING
Mayo Jacksonville, Jacksonville
RECRUITING
University of Florida, Gainesville
RECRUITING
Medical College of Wisconsin, Milwaukee
RECRUITING
Mayo Clinic, Rochester
RECRUITING
University of Utah, Salt Lake City
RECRUITING
Oregon Health and Sciences University, Portland
RECRUITING
University of Washington, Seattle
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
New York University
OTHER
Massachusetts General Hospital
OTHER
University of Florida
OTHER